These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6342734)

  • 21. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
    Mauri D; Pavlidis N; Ioannidis JP
    J Natl Cancer Inst; 2005 Feb; 97(3):188-94. PubMed ID: 15687361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence.
    Metz JM; Schultz DJ; Fox K; Glick J; Solin LJ
    Cancer J Sci Am; 1999; 5(2):77-83. PubMed ID: 10198729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast-conserving surgery in the neoadjuvant setting.
    Brenin DR; Morrow M
    Semin Oncol; 1998 Apr; 25(2 Suppl 3):13-8. PubMed ID: 9566202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symposium on the management of early breast cancer (stages I and II). Part II: Clinical experience with treatment methods. 4. Adjuvant chemoimmunotherapy.
    Bowman DM
    Can J Surg; 1981 Jul; 24(4):375-8. PubMed ID: 7023633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
    Willner J; Kiricuta IC; Kölbl O
    Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?
    Dixon JM
    Breast; 2008 Aug; 17(4):353-60. PubMed ID: 18490163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The disease-free interval in breast cancer trials: scientific or spurious?
    Mueller CB
    Surgery; 1991 Oct; 110(4):629-34; discussion 634-5. PubMed ID: 1925953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tamoxifen adjuvant delays early breast cancer. Results of a cooperative randomized trial].
    Delozier T; Switsers O; Génot JY; Ollivier JM; Héry M; Namer M; Frenay M; Kerbrat P; Julien JP; Naja A; Janvier M; Macé-Lesec'h J
    Bull Cancer; 1997 Jan; 84(1):25-30. PubMed ID: 9180855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.
    Wapnir IL; Anderson SJ; Mamounas EP; Geyer CE; Jeong JH; Tan-Chiu E; Fisher B; Wolmark N
    J Clin Oncol; 2006 May; 24(13):2028-37. PubMed ID: 16648502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Methodological features of assessing the effectiveness of adjuvant therapy in clinical trials].
    Dvoĭrin VV
    Vopr Onkol; 1986; 32(6):18-22. PubMed ID: 3523991
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunotherapy with decaris in the early stages of breast cancer].
    Polevaia EB; Derevnina NA; Trubchaninova LP; Veskova TK
    Vopr Onkol; 1988; 34(10):1182-8. PubMed ID: 3055672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adjuvant therapy in breast neoplasms].
    Senn HJ
    Aktuelle Probl Chir Orthop; 1982; 22():52-60. PubMed ID: 6121514
    [No Abstract]   [Full Text] [Related]  

  • 37. [High-dose chemotherapy for treatment of breast cancers].
    Tajima T; Ohta M; Tokuda Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():223-7. PubMed ID: 11025999
    [No Abstract]   [Full Text] [Related]  

  • 38. Complications and toxic manifestations of surgical adjuvant chemotherapy for breast cancer.
    Cohn I
    Surg Gynecol Obstet; 1968 Dec; 127(6):1201-9. PubMed ID: 4973320
    [No Abstract]   [Full Text] [Related]  

  • 39. [Primary surgical treatment of breast cancer].
    Müller W; Steiner A
    Ther Umsch; 1971 Dec; 28(12):830-5. PubMed ID: 5158873
    [No Abstract]   [Full Text] [Related]  

  • 40. The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.
    Fisher B; Redmond C; Fisher ER
    Cancer; 1980 Aug; 46(4 Suppl):1009-25. PubMed ID: 6994873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.